ISSN (Online) : 2349- 2759

ISSN (Print)    : 2395- 1095


About Us

Journal of Innovations in Pharmaceuticals and Biological Sciences is a peer reviewed Open Access International Journal of best quality dedicated to various disciplines of pharmaceutical and biological Sciences. JIPBS publishes Original Research Articles, Reviews/Mini-Reviews, Opinions & Perspectives, Book Reviews for the Pharmaceutical Sciences, Short Communications, and Research Notes. The journal covers the following major areas of Pharmaceuticals and Biological Sciences.

Pharmaceutical Sciences : Pharmaceutics, Novel drug delivery systems, Nanotechnology, Pharmacology, Pharmacognosy, Analytical chemistry, Pharmacy Practice, Pharmacogenomics, Polymer Sciences, Biomaterial Science, Medicinal chemistry, Natural chemistry, Biotechnology, Pharmacoinformatics, Biopharmaceutics, Pharmaceutical Biochemistry, Organic Chemistry, Inorganic Chemistry, Pharmaceutical Technology, Microbiology, Clinical Research.

Biological Sciences : Biochemistry, Biotechnology, Bioinformatics, Cell biology, Microbiology, Allied Sciences, Molecular biology, Neurobiology, Cytology, Pathology, Immunobiology.

Open Access Policy


JIPBS supports open access publication for each manuscript.  All the manuscripts published in JIPBS are made freely accessible online immediately after publication in an easily readable format, without paying any subscription fee.

Manuscript can be shared and adapted provided attribution for the work is given and that the work is not used for commercial purposes.


Peer-review Policy


All the manuscripts submitted to JIPBS will be subjected to single-blind peer review process, where authors remain anonymous throughout the review process.

When the journal receives a new submission, the editorial staff then performs an initial review of the manuscript to determine its topical relevance, adherence to the formatting guidelines, and absence of plagiarism in both textual and scientific content. If the manuscript passes this initial review, it is forwarded for peer review process to suitable expert in respective subject area.

The reports of the reviewer will be considered while deciding on acceptance/revision or rejection of a manuscript

Editor-In-Chief will make the final decision, based on reviewer’s comments

In case, authors challenge editor's negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.


Copyright Policies


All the articles published in JIPBS are distributed under a creative commons license. The journal allows the author(s) to hold the copyright of their work without restrictions. Journal also allows the author(s)to retain publishing rights of their work.


Clinical Trial Registry

For clinical trials,the Clinical Trials Registry identifier number and platform should be provided.

Publication Ethics and Malpractice Statement


The Journal of Innovations in Pharmaceutical and Biological sciences (JIPBS) is dedicated to following best practices on ethical matters, errors and retractions. The prevention of publication malpractice is one of the important responsibilities of the editorial board. Any kind of unethical behavior is not acceptable. Authors submitting manuscripts to JIPBS affirm that manuscript contents are original.


Role/Duties/Responsibility of Editor

  1. Publication Decisions: Based on the review report of the editorial review board, the editor can accept, reject, or request modifications to the manuscript.
  2. Fair Review: The editor must ensure that each manuscript received is reviewed for its intellectual content without regard to sex, gender, race, religion, citizenship, etc. of the authors.
  3. Confidentiality: The editor must ensure that information regarding manuscripts submitted by the authors is kept confidential.
  4. Disclosure and Conflicts of Interest: The editor of Journal will not use unpublished materials disclosed in a submitted manuscript for his/her own research without written consent of the author.


Role/Duties/Responsibility of Reviewers

  1. Confidentiality: Reviewers must consider all received manuscripts for review as confidential documents. Received manuscripts must not be seen by or discussed with others.
  2. Objectivity: Review of submitted manuscripts must be done objectively and the reviewers should express their views clearly with supporting arguments.
  3. Qualifications: Reviewers who believe that they are not qualified to review a received manuscript should inform the JIPBS editors promptly and decline the review process.
  4. Disclosure: Information or ideas obtained through blind reviews must be kept confidential and must not be used by reviewers for personal benefits or in any kind of work which is helpful and benefit to him or his subordinates current research work.
  5. Conflict of Interest: Reviewers should refuse the review of manuscripts in which they have conflicts of interest emerging from competitive, collaborative, or other relationships and connections with any of the authors, companies, or institutions connected to the manuscripts.
  6. Substantial Similarity: Reviewers should inform editors about significant resemblances or overlap between received manuscripts and any other published manuscripts that reviewers are aware of.
  7. Contribution to Editorial Decisions: Reviewers assist editors in making editorial publication decisions, and also assist authors in improving their submitted manuscripts, through the editorial communications with authors. Therefore, reviewers should always provide explicit and constructive feedback to assist authors in improving their work.


Role/Duties/Responsibility of Authors

  1. Originality: Authors submitting manuscript to the JIPBS should be original and must ensure that this submission is neither currently under consideration for publication elsewhere, nor has been published as a copyrighted material before. If authors have used the ideas, and/or words of others researchers, they should acknowledge that through proper quotes or citations.
  2. Plagiarism: Plagiarism appears into various types, such as claiming the authorship of work by others, copying and paraphrasing major parts of others research (without attribution), and using the results of research conducted by other researchers. However, any type of plagiarism is unacceptable and is considered unethical publishing behavior. Such manuscripts will be rejected. If any infringement/ objection/ or complaint happens with that published manuscript author will be the sole responsible of that particular manuscript and liable to provide the compensation/claim or any other form whichever is necessary to settle the dispute or issue.
  3. Authorship of Manuscripts: Authorship of a manuscript should be limited to authors who have made significant contributions and the names of authors should be ranked by efforts. The corresponding author must ensure that all listed coauthors have seen and approved the final version of the manuscript (as it appeared in the proofreading copy) and agreed to the policies of publication in the JIPBS. Authors can permit others to replicate their work. Main author to be indicated with * mark who will be the corresponding author.
  4. Multiple or Concurrent Publication: Authors should not publish manuscripts describing essentially the same research in more than one journal. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable. This action leads to the rejection of the submitted manuscripts or even removal after publication of the same.
  5. Acknowledgement of the Work of Others: Authors should always properly acknowledge the work of others. Authors should cite publications that have significant contribution to their submitted manuscripts. Unacknowledged work of others contributing to manuscripts is unethical behavior and is unacceptable. Such manuscripts will be rejected.
  6. Accuracy: Reported objectives, discussions, data, statistical analysis, and results should be accurate. Fraudulent or knowingly inaccurate results constitute unethical behavior and are unacceptable. Such manuscripts will be rejected.
  7. Data Access and Retention: Authors may be asked to provide the raw data in connection with manuscripts for editorial review including excel sheets, figures, software report, calculations sheets etc , and should be prepared to provide public access to such data if possible. However, such authors should be prepared to retain data for a reasonable time after publication.
  8. Hazards and Human or Animal Subjects: If a research study involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author(s) must clearly identify these in the submitted manuscript. Authors should also inform participating human subjects about the purpose of the study. Author should also furnish the permission to animal ethical committee whenever if required.
  9. Conflicts of Interest: Authors in their manuscript(s), authors should disclose any financial or other substantive conflict of interest that might influence the results or interpretation of their manuscript.
  10. Copyright of Accepted Manuscripts: Authors of accepted manuscripts for publication in the JIPBS agree that the copyright will be transferred to JIPBS and all authors should sign copyright forms. However, those authors have the right to use their published manuscripts fairly, such as teaching and nonprofit purposes. Without copyright transfer agreement manuscript will not proceed for further consideration with respect to publication
  11. Substantial errors in published Manuscripts: When authors discover substantial errors or inaccuracy in their own published manuscripts, it is the authors’ responsibility to promptly inform the JIPBS editors or publisher, and cooperate with them to correct their manuscripts through mail only.
  12. Acknowledgement of Indirect Contributors and Financial Supporters: Authors should acknowledge individuals whose contributions are indirect or marginal (e.g., colleagues or supervisors who have reviewed drafts of the work or provided proofreading assistance, and heads of research institutes, centers and labs should be named in an acknowledgement section at the end of the manuscript, immediately preceding the List of References). In addition, all sources of financial support for the research project should be disclosed. It is the author responsibility for acknowledging the names in their respective manuscripts. Additions of the name or suggestions after publication will not entertained from author or any other person or institute which has any contribution of funding or in any other format.



The author(s) of each article appearing in this Journal is/are solely responsible for the content thereof; neither the Journal of Innovations in Pharmaceutical and Biological Sciences nor its editors or publisher or anyone else involved in creating,producing or distribution assumes any liability or responsibility for the accuracy, completeness, or usefulness of any information provided in the Journal, nor shall they be liable for any direct, indirect,incidental, special, consequential or punitive damages arising out of the use of the Journal of Innovations in Pharmaceutical and Biological Sciences.